Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ASHOK BALASUBRAMANYAM and FAROOK JAHOOR.
ASHOK BALASUBRAMANYAM
Connection Strength
3.295
FAROOK JAHOOR
  1. Amino acids and CART distinguish A-?+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises. J Clin Endocrinol Metab. 2025 Jan 16.
    View in: PubMed
    Score: 0.987
  2. Metabolomics Profiling of Patients With A-?+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis. Diabetes. 2021 08; 70(8):1898-1909.
    View in: PubMed
    Score: 0.766
  3. Random C-Peptide and Islet Antibodies at Onset Predict ? Cell Function Trajectory and Insulin Dependence in Pediatric Diabetes. Endocr Pract. 2024 Dec; 30(12):1149-1157.
    View in: PubMed
    Score: 0.242
  4. Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
    View in: PubMed
    Score: 0.221
  5. Arginine Metabolism Is Altered in Adults with A-?+?Ketosis-Prone Diabetes. J Nutr. 2018 02 01; 148(2):185-193.
    View in: PubMed
    Score: 0.152
  6. HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation. Sci Transl Med. 2013 Nov 27; 5(213):213ra164.
    View in: PubMed
    Score: 0.114
  7. Pathogenesis of A??? ketosis-prone diabetes. Diabetes. 2013 Mar; 62(3):912-22.
    View in: PubMed
    Score: 0.106
  8. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome. Metabolism. 2012 Oct; 61(10):1395-403.
    View in: PubMed
    Score: 0.102
  9. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011 Sep; 94(3):847-53.
    View in: PubMed
    Score: 0.097
  10. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011 Jan; 34(1):162-7.
    View in: PubMed
    Score: 0.092
  11. Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E40-8.
    View in: PubMed
    Score: 0.069
  12. In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am J Clin Nutr. 2006 Jul; 84(1):197-203.
    View in: PubMed
    Score: 0.068
  13. Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome. Am J Clin Nutr. 2006 Jul; 84(1):204-11.
    View in: PubMed
    Score: 0.068
  14. Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. Am J Clin Nutr. 2005 Jun; 81(6):1405-10.
    View in: PubMed
    Score: 0.063
  15. Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. Curr Atheroscler Rep. 2004 May; 6(3):173-9.
    View in: PubMed
    Score: 0.059
  16. Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E332-7.
    View in: PubMed
    Score: 0.052
  17. Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. Metabolism. 2011 Jun; 60(6):754-60.
    View in: PubMed
    Score: 0.023
  18. Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults. J Clin Endocrinol Metab. 2003 Dec; 88(12):5827-33.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.